Istanbul Bilgi University School of Law, 2019
Istanbul, 2020
Related contents
13 October 2026
Borderline products: distinguishing medicinal products, medical devices and cosmetics under Turkish law
A critical consideration before placing health and personal care products on the market is determining their correct regulatory…
25 September 2026
Recent developments in healthcare legislation – Issue 2026/2
On 21 April 2026, the Turkish Medicines and Medical Devices Agency published amendments to the guideline with a view to streamlining the…
25 August 2026
Turkish competition law newsletter – Issue 2026/3
Turkish competition enforcement has entered a phase in which the Turkish Competition Authority’s most consequential interventions…
6 July 2026
Legal developments regarding herbal medicinal products, foods for special medical purposes and medical devices
The Regulation on Aromatherapeutic Products and the Regulation on Medicinal Herbal Teas, together with the amendments to the Regulation on…
21 May 2026
Turkish competition law newsletter – Issue 2026/2
The Turkish competition landscape rarely stands still, and this Spring 2026 edition of the Paksoy Turkish Competition Law Newsletter…
5 May 2026
The Turkish Competition Authority updates its mergers and acquisitions guidelines
Following the significant amendments made on 11 February 2026 to the Communiqué Concerning the Mergers and Acquisitions Calling for the…
13 April 2026
Recent developments in healthcare legislation – Issue 2026/1
The Guideline on Trust Practices in Clinical Trial Applications published by the Turkish Medicines and Medical Devices Agency was updated…
19 February 2026
Turkish Competition Law Newsletter – Issue 2026/1
Welcome to the 2026 Winter edition of the Paksoy Turkish Competition Law Newsletter series.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.